The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision today vacating and remanding with ...
The U.S. Patent and Trademark Office (USPTO) recently released new guidance for practitioners using artificial intelligence ...
“The stated goal of facilitating commercialization in particular may seem contradictory to some, considering the ...
“[T]he Federal Circuit noted that questions about a party’s ability to license patent rights do not provide a reasonable ...
“Using section 1498 would not significantly reduce drug costs because, as courts have repeatedly recognized, the law requires the government to provide ‘reasonable and entire compensation’ for any ...
Expansion to FTC’s Orange Book Campaign Leads to Calls for More Clarity from Pharmaceutical Industry
On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper ...
The U.S. Senate Judiciary Committee’s Subcommittee on Intellectual Property met today to hear from six witnesses about a ...
Epstein Becker & Green is seeking an intellectual property associate to join its Health Care & Life Sciences practice in our ...
Standard Essential Patent (SEP) litigation is global and SEP owners often follow a strategy to enforce their SEPs in multiple ...
President Biden issued an executive order (EO) on artificial intelligence on October 30, 2023, announcing a series of agency ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential trademark decision affirming a Trademark ...
GlaxoSmithKline filed a four-count civil action for patent infringement in the United States District Court for the District ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results